S. Aubrey Stoch
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Diabetes Treatment and Management, Drug Transport and Resistance Mechanisms, Pharmacological Effects and Toxicity Studies, Bone health and osteoporosis research
Most-Cited Works
- → [18F]MK-9470, a positron emission tomography (PET) tracer forin vivohuman PET brain imaging of the cannabinoid-1 receptor(2007)313 cited
- → Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study(2019)166 cited
- → Single‐Dose Administration of MK‐0657, an NR2B‐Selective NMDA Antagonist, Does Not Result in Clinically Meaningful Improvement in Motor Function in Patients With Moderate Parkinson's Disease(2009)62 cited
- → Native Oxyntomodulin Has Significant Glucoregulatory Effects Independent of Weight Loss in Obese Humans With and Without Type 2 Diabetes(2018)54 cited
- → A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal Impairment(2020)52 cited
- → Pharmacokinetics and Pharmacodynamics of MK‐5046, a Bombesin Receptor Subtype‐3 (BRS‐3) Agonist, in Healthy Patients(2011)44 cited
- → Safety, tolerability, and pharmacokinetics of single‐ and multiple‐dose administration of islatravir (MK‐8591) in adults without HIV(2021)43 cited
- → Pharmacokinetics and Pharmacodynamics of Omarigliptin, a Once‐Weekly Dipeptidyl Peptidase‐4 (DPP‐4) Inhibitor, After Single and Multiple Doses in Healthy Subjects(2016)33 cited
- → Effect of Different Durations and Formulations of Diltiazem on the Single-Dose Pharmacokinetics of Midazolam: How Long Do We Go?(2011)32 cited
- → Pharmacodynamic effects of suvorexant and zolpidem on EEG during sleep in healthy subjects(2016)29 cited